The MRC/BHF Centre of Research Excellence (CoRE) in Advanced Cardiac Therapies was founded in 2025 with UK government funding from the Medical Research Council and charity funding from the British Heart Foundation.
The MRC/BHF CoRE in Advanced Cardiac Therapies began on 1 January 2025, with a duration of 14 years. Funding has been secured for an initial 7 year period.
An experienced leadership team are responsible for delivering CoRE research and impact. Day-to-day management is supported by the CoRE's own operations team alongside staff and students working across all partner organisations.
The work of our CoRE is overseen by our Independent Scientific Advisory Board, a group of leading scientists, experts in clinical translation and including patient representation.
Our funders
Our funders, the UKRI Medical Research Council and British Heart Foundation, fund our core activities in a 50:50 arrangement totalling £23.71 million over the first 7 years of our 14 year plan.
Records are publicly available through UKRI's Gateway to Research for our main award (MR/Z504658/1) and training award (MR/Z504865/1).
Our principal partners
Our CoRE is a collaboration between King's College London, the University of Edinburgh and the University of Oxford.
For the purposes of grant administration, King's College London is the lead research organisation.